OGN vs SATS · P/E 3.4, rev $3.02B vs rev $15.83B
Organon & Co (OGN) versus EchoStar Corporation (SATS) — a side-by-side from cached financials, not a winner call.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
EchoStar Corporation (SATS) is a telecom services company listed on NASDAQ.
Latest reported OGN revenue for 2026-06-30 was $3.02B. Net income was $254.0M. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Latest reported SATS revenue for 2024-12-31 was $15.83B. Net income was -$124.5M. Revenue was up 280.2% from 2023-12-31 to 2024-12-31. SATS currently screens at market cap $32.37B.
OGN currently screens at market cap $2.52B and trailing P/E 3.4. SATS currently screens at market cap $32.37B.
Not investment advice. Open the OGN and SATS stock pages for the full models.
Not investment advice.